Kenji Hashimoto

Professor

Chiba Daigaku

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Kenji Hashimoto is a faculty member at Chiba Daigaku in Japan. His research encompasses areas such as immune regulation, neuroinflammation, psychological stress and depression, and cardiovascular diseases. Recent publications include investigations into D-lactate's role in immune regulation, central-peripheral neuroimmune dynamics, and the therapeutic mechanisms of various compounds in treating cardiovascular conditions.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

Yong Yang

Assistant professor

JAPAN

View details

Akifumi Eguchi

Assistant professor

Chiba University

JAPAN

View details

Julie Gavin-Ramain

Head of research

SWITZERLAND

View details

Chin B. Eap

SWITZERLAND

View details

Dr. Ines Khadimallah

University of Bern

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kenji Hashimoto

Research Interests

Explore related searches

Contact this professor

About

Articles (29)

D-lactate in immune regulation and neuroinflammation: beyond microbial fermentation

Central-peripheral neuroimmune dynamics in psychological stress and depression: insights from current research

Correction: Central-peripheral neuroimmune dynamics in psychological stress and depression: insights from current research

Cardiovascular diseases and depression: A meta-analysis and Mendelian randomization analysis

Comparative analysis of L- and D-lactic acid levels in the brain and periphery organs of germ-free and SPF mice

Correction: Cardiovascular diseases and depression: A meta-analysis and Mendelian randomization analysis

Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Constipation-Predominant Irritable Bowel Syndrome: A Single-Center, Single-Blind, Randomized Controlled Trial

Noradrenergic modulation of glymphatic clearance: implications for neuropsychiatric disorders and mortality

Therapeutic mechanisms of Acorus tatarinowii and its bioactive compounds in cardiovascular diseases: A comprehensive review

Variability in Oxytocin Blood Levels in Rats: A Review and Experimental Insights

Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study

Repeated ( S )-ketamine administration ameliorates the spatial working memory impairment in mice with chronic pain: role of the gut microbiota–brain axis

Relationship between hearing loss and depression: A cross-sectional analysis from the National Health and Nutrition Examination Survey 2015–2018

Therapeutic Potential of Ketamine in Management of Epilepsy: Clinical Implications and Mechanistic Insights

Dietary sulforaphane glucosinolate mitigates depression-like behaviors in mice with hepatic ischemia/reperfusion injury: A role of the gut–liver–brain axis

Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: A meta-analysis of randomized controlled trials

Viewpoints Sigma-1 receptor agonist fluvoxamine for multiple sclerosis

Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023

Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?

Repeated use of 3,4-methylenedioxymethamphetamine is associated with the resilience in mice after chronic social defeat stress: A role of gut–microbiota–brain axis

Beneficial effects of arketamine on the reduced bone mineral density in susceptible mice after chronic social defeat stress: Role of the gut–microbiota–bone–brain axis

Impact of broad-spectrum antibiotics on the gut–microbiota–spleen–brain axis

Infusions of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produce antidepressant-like effects on learned helplessness rats through BDNF-TrkB signaling and AMPA receptor activation, and strengthen learning ability

Arketamine for cognitive impairment in psychiatric disorders

The role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in chronic inflammatory pain and comorbid spatial working memory impairment in complete Freund's adjuvant mice

A role of splenic heme biosynthesis pathway in the persistent prophylactic actions of arketamine in lipopolysaccharide-treated mice

Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein–Barr virus and the gut–brain axis

Mesenchymal stem-cell-derived microvesicles ameliorate MPTP-induced neurotoxicity in mice: a role of the gut–microbiota–brain axis

Risk of esketamine anesthesia on the emergence delirium in preschool children after minor surgery: a prospective observational clinical study

Collaborators (5)

Yong Yang

Akifumi Eguchi

Julie Gavin-Ramain

Chin B. Eap

Dr. Ines Khadimallah

Make your next move.